Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

2(66.7%)

Phase 1

1(33.3%)

3Total

N/A(2)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT06228807Completed

Clinical Characteristics and Predictors of Adverse Outcomes in HFpEF

Role: lead

NCT06698432Completed

SHR Predicts CMD in Patients with CCS

Role: lead

NCT06690684Enrolling By Invitation

Identification and Functional Study of Novel Biomarkers for Cardiovascular Diseases

Role: lead

NCT06385782Completed

Exploring HRV in Antarctic Overwintering Members of Asia

Role: lead

NCT06190704Completed

Prognostic Significance of CMD Assessed by IMR in HCM Patients

Role: lead

NCT05935436Not ApplicableUnknown

Cardiac Shock Wave Therapy for the Treatment of Myocardial Infarction With Non-obstructive Coronary Arteries

Role: lead

NCT05354128Not ApplicableUnknown

Thrombolysis in STEMI Patients Compared With pPCI on Recanalization Time in the Context of the COVID-19 Outbreak.

Role: lead

NCT03735251Completed

Epidemic Profile of Left Ventricular Diastoic Dysfunction in the Community Elderly and Establishing Prediction Model: the Northern Shanghai Study

Role: lead

NCT03802929Unknown

Diagnostic and Prognostic Prediction Models for Chinese Patients With Venous Thromboembolism

Role: lead

NCT02937025Phase 1Unknown

Study of Safety and Efficacy of a Left Atrial Appendage Occulder

Role: lead

All 10 trials loaded